• Mashup Score: 11
    Evolving Omicron Subvariants Are More Resistant to Antibody Therapy - 2 year(s) ago

    Most monoclonal antibody therapies that neutralized early variants of the SARS-CoV-2 virus are less effective or not effective against the BA.2.12.1, BA.4, and BA.5 Omicron subvariants that currently make up almost 99% of infections in the United States, according to a report in Nature.

    Source: jamanetwork.com
    Categories: General Medicine Journals and Societies, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JAMA_current
      JAMA_current

      Laboratory tests found that almost all of 21 monoclonal antibodies targeting #SARSCoV2 spike proteins lost neutralizing activity completely or partially against BA.2.12.1 and BA.4/5 (Omicron subvariants). #MedicalNews https://t.co/o1bUNBFh5Y #MedIllustration: @IDrawPicsAllDay https://t.co/I7ilEsoH4W